Eclampsia primary prevention: Difference between revisions

Jump to navigation Jump to search
 
Line 4: Line 4:


Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
==Prevention==
==Overview==
Detection and management of preeclampsia is critical to reduce the risk of eclampsia. Appropriate management of patients with preeclampsia generally involves the use of magnesium sulfate as an agent to prevent convulsions, and thus preventing eclampsia.
Detection and management of preeclampsia is critical to reduce the risk of eclampsia. Appropriate management of patients with preeclampsia generally involves the use of magnesium sulfate as an agent to prevent convulsions, and thus preventing eclampsia.


==Prevention==
Prevention of convulsion is usually done using [[magnesium sulfate]] (4-6 g loading dose in 100 ml iv fluid given over 15-20 minutes, then 2g per hour as a continuous infusion).<ref name=ACOG>{{cite journal |author=ACOG| title=  Diagnosis and Management of Preeclampsia and Eclampsia |journal=ACOG Practice Bulletin # 33, 2002,}}</ref> Evidence for the use of magnesium sulfate came from the international MAGPIE study.<ref>{{cite journal |author=Frayling, Frayling |title=The Magpie Trial follow up study: outcome after discharge from hospital for women and children recruited to a trial comparing magnesium sulphate with placebo for pre-eclampsia [ISRCTN86938761] |journal= |volume=4 |issue=1 |pages=5 |year=2004 |pmid=15113445}}</ref>
Prevention of convulsion is usually done using [[magnesium sulfate]] (4-6 g loading dose in 100 ml iv fluid given over 15-20 minutes, then 2g per hour as a continuous infusion).<ref name=ACOG>{{cite journal |author=ACOG| title=  Diagnosis and Management of Preeclampsia and Eclampsia |journal=ACOG Practice Bulletin # 33, 2002,}}</ref> Evidence for the use of magnesium sulfate came from the international MAGPIE study.<ref>{{cite journal |author=Frayling, Frayling |title=The Magpie Trial follow up study: outcome after discharge from hospital for women and children recruited to a trial comparing magnesium sulphate with placebo for pre-eclampsia [ISRCTN86938761] |journal= |volume=4 |issue=1 |pages=5 |year=2004 |pmid=15113445}}</ref>



Latest revision as of 19:56, 11 February 2013

Eclampsia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Differentiating Eclampsia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Eclampsia primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eclampsia primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eclampsia primary prevention

CDC on Eclampsia primary prevention

Eclampsia primary prevention in the news

Blogs on Eclampsia primary prevention

Directions to Hospitals Treating Eclampsia

Risk calculators and risk factors for Eclampsia primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Detection and management of preeclampsia is critical to reduce the risk of eclampsia. Appropriate management of patients with preeclampsia generally involves the use of magnesium sulfate as an agent to prevent convulsions, and thus preventing eclampsia.

Prevention

Prevention of convulsion is usually done using magnesium sulfate (4-6 g loading dose in 100 ml iv fluid given over 15-20 minutes, then 2g per hour as a continuous infusion).[1] Evidence for the use of magnesium sulfate came from the international MAGPIE study.[2]

References

  1. ACOG. "Diagnosis and Management of Preeclampsia and Eclampsia". ACOG Practice Bulletin # 33, 2002,.
  2. Frayling, Frayling (2004). "The Magpie Trial follow up study: outcome after discharge from hospital for women and children recruited to a trial comparing magnesium sulphate with placebo for pre-eclampsia [ISRCTN86938761]". 4 (1): 5. PMID 15113445.

Template:WH Template:WS